ImmunityBio
The Research Associate II, Analytical Development supports adoptive cell therapy projects by developing, optimizing, and validating bioassays. This role involves performing cell-based assays, characterizing cells using advanced analytical technologies, and maintaining laboratory equipment to ensure efficient operations. The position requires collaboration with cross-functional teams to advance the development of cell therapy products and support process improvements.
Headquarters
San Diego, California, United States
Company Size
501-1000 employees
Founded
2014
We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.
ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data
3 days ago
Is It Time To Reassess ImmunityBio (IBRX) After Its Recent Share Price Surge
2 days ago
ImmunityBio’s Stock Sees a Huge Boost
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ImmunityBio.
ImmunityBio (NASDAQ:IBRX) Stock Price Up 3.2% - What's Next?
1 day ago
Analytical Development Scientist – Bioassay
Novartis
Senior Associate Scientist - Discovery Research, Regeneron Cell Medicines
Regeneron Pharmaceuticals
Scientist, Analytical Cell Line Engineering & Bioassay Development
BioLife Plasma Services
Senior Scientist I, Analytical Development, Biologics CMC
Exelixis
Analytical Development Bioassay Scientist
Novartis
Technical Development
Moderna